A Study of Ivonescimab in People With Endometrial and Cervical Cancers

NCT ID: NCT06925724

This clinical trial is investigating a new treatment called ivonescimab for women with endometrial cancer or cervical cancer that has come back or spread after previous treatments. The goal is to s...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Harrison, New York, United States +5 more

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

NCT ID: NCT06459180

This clinical trial is studying a treatment called sacituzumab tirumotecan for women with recurrent or metastatic cervical cancer, which means the cancer has come back or spread after initial treat...

Recruiting

Phase: PHASE3 Type: interventional Locations: Barcelona, Cataluna, Spain, Warszawa, Mazowieckie, Poland +246 more

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT ID: NCT05527184

This clinical trial, called IMGN151-1001, is testing a new treatment called IMGN151 for women with certain types of recurrent cancers, specifically endometrial cancer and high-grade ovarian, perito...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +37 more

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05581004

This clinical trial is testing a new treatment called RO7502175, both on its own and in combination with another medication called atezolizumab. The study is designed for adults who have locally ad...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, Atlanta, Georgia, United States +41 more

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT ID: NCT06238479

This clinical trial is investigating a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors that have come back or spread to other parts of the body. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Boston, Massachusetts, United States +34 more

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT ID: NCT03556228

This clinical trial is studying a new medication called VMD-928, which is being tested for patients with certain types of advanced cancers and lymphomas that have not responded to standard treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, Duarte, California, United States +32 more

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

NCT ID: NCT06977594

This clinical trial is studying a new approach to help women with ovarian, endometrial, or cervical cancer who are receiving chemotherapy. The researchers want to find out if a treatment called imm...

Not yet recruiting

Phase: NA Type: interventional Locations: Seoul, , Korea, Republic Of

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT ID: NCT06999187

This clinical trial is looking at a new treatment called DR-0202 for patients with certain types of advanced cancers, including triple-negative breast cancer and non-small cell lung cancer, among o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Denver, Colorado, United States +8 more

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT ID: NCT06239194

This clinical trial is testing a new treatment called MDX2001 for patients with advanced solid tumors, which are cancers that form in organs or tissues, such as breast, lung, or colorectal cancer. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +4 more

ASk Questions in GYnecologic Oncology (ASQ-GYO)

NCT ID: NCT06339827

The ASk Questions in GYnecologic Oncology (ASQ-GYO) clinical trial is studying a special tool called the ASQ-GYO question prompt list. This tool is designed to help patients with gynecologic cancer...

Recruiting

Phase: NA Type: interventional Locations: Detroit, Michigan, United States

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT06172478

This clinical trial is studying a new treatment called HER3-DXd for patients with advanced solid tumors, which are cancers that have spread and cannot be treated with surgery or radiation. The tria...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States, Madrid, , Spain +69 more

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

NCT ID: NCT06535607

The eVOLVE-02 clinical trial is studying a new treatment called volrustomig for patients with advanced cervical cancer or head and neck cancers. This trial will look at how well volrustomig works o...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China, Chongqing, , China +20 more

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

NCT ID: NCT05051722

This clinical trial is studying a new type of test that aims to detect certain gynecologic cancers—specifically endometrial, ovarian, and cervical cancers—using special markers found in vaginal flu...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States, Milwaukee, Wisconsin, United States +18 more

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

NCT ID: NCT06771193

This clinical trial is a study that looks at the characteristics and treatment of cervical cancer in women in Italy. It focuses on patients who have locally advanced, recurrent, or metastatic cervi...

Recruiting

Type: observational Locations: Aviano, Pordenone, Italy, Mestre, Venezia, Italy +9 more

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

NCT ID: NCT05475171

The TRACTION clinical trial is investigating whether a new treatment called MGD019 can help control advanced cervical cancer in patients who have not yet received any treatment. This trial is speci...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

NCT ID: NCT06952660

This clinical trial is focused on a treatment called TIVDAK for women with cervical cancer that has come back after chemotherapy. The main goal of the study is to learn more about any side effects ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Las Vegas, Nevada, United States, Shreveport, Louisiana, United States +5 more

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT ID: NCT05078047

This clinical trial is investigating whether a less frequent administration of immunotherapy (IO) can be just as effective as the standard treatment schedule for patients with certain types of adva...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nice, , France, Rennes, , France +38 more

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT ID: NCT05891171

This clinical trial is studying a new treatment called AB598 for patients with advanced cancers, including types like bladder, cervical, lung, and breast cancer, among others. The main goal is to s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, New Orleans, Louisiana, United States +25 more

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT ID: NCT04038619

This clinical trial is investigating whether a treatment called fecal microbiota transplantation (FMT) can help patients with certain types of cancer who are experiencing diarrhea or colitis caused...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Main Menu

Clinical Trials for Cervical Cancer

316 Active Trials Found

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

ASk Questions in GYnecologic Oncology (ASQ-GYO)

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Related Conditions